Plant Comparison
Centaury vs Goldenseal
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Centaury and Goldenseal: they share 5 indicated uses (arthritis / joint pain, bloating, indigestion, …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Centaury | Goldenseal | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 5/10 | Stronger for Goldenseal |
| Bloating | 1/10 | 5/10 | Stronger for Goldenseal |
| Indigestion | 1/10 | 5/10 | Stronger for Goldenseal |
| Inflammation (general) | 1/10 | 5/10 | Stronger for Goldenseal |
| Skin irritation | 1/10 | 5/10 | Stronger for Goldenseal |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The intensely bitter principles that stimulate digestive secretions.
Berberine is the main antimicrobial, hypoglycaemic and hypolipidaemic constituent. Notably, whole-leaf extracts are more potent against MRSA than isolated berberine (owing to efflux-pump-inhibitory flavonoids) and show quorum-quenching, anti-virulence activity.
Pharmacological Actions
Digestive aid for mild dyspeptic complaints such as indigestion and bloating (stimulates gastric and bile secretion) - a comprehensive review also documents gastroprotective, hepatoprotective and anti-inflammatory activity
Aromatic bitter tonic for temporary loss of appetite
Digestive aid for mild dyspeptic complaints such as indigestion and bloating (stimulates gastric and bile secretion) - a comprehensive review also documents gastroprotective, hepatoprotective and anti-inflammatory activity
Digestive aid for mild dyspeptic complaints such as indigestion and bloating (stimulates gastric and bile secretion) - a comprehensive review also documents gastroprotective, hepatoprotective and anti-inflammatory activity
Anti-inflammatory and astringent for inflamed mucous membranes (sore-throat gargle, mouth)
Antimicrobial (berberine) - supports skin, mucosal and gastrointestinal infections and sore throat
Anti-inflammatory and astringent for inflamed mucous membranes (sore-throat gargle, mouth)
Traditional & Indicated Uses
inferred from gastroprotective action
Aromatic bitter tonic for temporary loss of appetite
inferred from anti-inflammatory action
Digestive aid for mild dyspeptic complaints such as indigestion and bloating (stimulates gastric and bile secretion) - a comprehensive review also documents gastroprotective, hepatoprotective and anti-inflammatory activity
inferred from hepatoprotective action
Digestive aid for mild dyspeptic complaints such as indigestion and bloating (stimulates gastric and bile secretion) - a comprehensive review also documents gastroprotective, hepatoprotective and anti-inflammatory activity
inferred from anti-inflammatory action
inferred from hepatoprotective action
inferred from anti-inflammatory action
Digestive / gastrointestinal support (traditional for dyspepsia and ulcers)
Antimicrobial (berberine) - supports skin, mucosal and gastrointestinal infections and sore throat; Topical for skin infections and irritation - whole-leaf extract is active in vitro against methicillin-resistant Staphylococcus aureus (MRSA)
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Anti-inflammatory and astringent for inflamed mucous membranes (sore-throat gargle, mouth); Antimicrobial (berberine) - supports skin, mucosal and gastrointestinal infections and sore throat
Safety, Cautions & Contraindications
Because bitters increase stomach-acid secretion, centaury is contraindicated in peptic (stomach or duodenal) ulcer disease and hyperacidity.
Traditional use only; appetite loss or dyspepsia that persists needs medical assessment. Use during pregnancy and breastfeeding is not recommended.
Contraindicated in pregnancy and breastfeeding: berberine crosses the placenta and into milk and can cause or worsen newborn jaundice (risk of kernicterus); do not give to infants.
Berberine strongly inhibits drug-metabolising enzymes (especially CYP3A4 and CYP2D6), so it can raise the blood levels of many medicines - a significant herb-drug-interaction risk. In a screen of commercial herbal products, goldenseal was among the most potent CYP2D6 inhibitors and also inhibited CYP3A4. High doses have shown possible liver, nerve and photo-toxicity.
External Ids
Botanical Description
Slender annual or biennial herb with a basal rosette of oval leaves and an erect, wiry, four-angled flowering stem branching near the top. Small, star-shaped, pink flowers with five pointed petals open only in sunshine, borne in dense, flat-topped clusters at the stem tips.[12]
Low, woodland perennial herb rising from a knotted, bright yellow rhizome with wiry yellow roots. Each stem bears two ragged, palmately lobed, maple-like leaves and a single small, inconspicuous greenish-white flower, followed by a raspberry-like cluster of red berries.[1]
Habitat
Grows in dry grassland, chalk downland, dunes and open woodland on well-drained, often calcareous soils; native to Europe, North Africa and Western Asia.[12]
Grows in rich, shaded deciduous woodland with humus-rich soil; native to eastern North America, now scarce in the wild due to overharvesting and largely supplied by cultivation.[1]
Harvesting
The flowering aerial parts are cut in summer while in flower, when the intensely bitter secoiridoid content is highest, and dried in a warm, shaded, airy place.[12]
The rhizome and root are dug in autumn from plants at least three to four years old, when berberine content is highest, then cleaned and dried; because wild populations are depleted, cultivated or sustainably sourced material is strongly preferred, and careful identification against the toxic mayapple and bloodroot, which share its woodland habitat, is essential before any wild-harvesting.[1]
Traditional Uses
Centaury is one of the classic European bitter digestive herbs, traditionally used for temporary loss of appetite and mild dyspeptic complaints such as indigestion and bloating, stimulating gastric and bile secretion.[12]
Goldenseal root has a Native American and, after adoption by Eclectic physicians, wider North American tradition as a bitter tonic and antimicrobial remedy for mucous-membrane infections, sore throat, digestive upset and topical skin infections, directly reflecting its high berberine content.[1]
Preparations
Dried herb macerated in cold water for several hours, which extracts the bitter principles while minimising extraction of harsher tannins; a traditional preparation method for bitters.
Dried herb infused briefly in hot water and taken shortly before meals as a bitter digestive tonic.
Tincture of the dried herb; the EU herbal monograph gives 1.5-5 g up to three times daily. Educational reference only, not a prescription.
Dried rhizome and root simmered in water as a traditional bitter antimicrobial tea, or used as a gargle for sore throat.
Tincture 1:10 in 60% ethanol of the dried rhizome and root, 2-4 ml three times daily per the WHO monograph Rhizoma Hydrastis. Educational reference only, not a prescription.
Extract standardised to berberine/hydrastine content, taken as capsules; whole-leaf extracts have shown stronger antimicrobial activity than isolated berberine in some studies.
Dosage
The EU herbal monograph gives 1-4 g of the comminuted herb in 200 mL of boiling water as an infusion, up to 4 times daily, in adults and elderly; a powdered herbal substance at 0.25-2 g up to 3 times daily, liquid extract 2-4 mL up to 3 times daily, and tincture 1.5-5 g up to 3 times daily are also listed. Not recommended under 18 years, and contraindicated in peptic ulcer. Educational reference only, not a prescription.
The WHO monograph on Rhizoma Hydrastis gives a daily dose of 0.5-1.0 g of the dried rhizome and root three times, or taken as a decoction; a 1:1 liquid extract in 60% ethanol at 0.3-1.0 mL three times; or a 1:10 tincture in 60% ethanol at 2-4 mL three times. For short-term use only, given goldenseal's potent CYP-enzyme inhibition and its contraindication in pregnancy. Educational reference only, not a prescription.
References
Lookalikes Review
Drug Class Interactions
Not documented
Dangerous Lookalikes
Not documented
References & Sources
- Tuluce, Y., Ozkol, H., Koyuncu, I. and Ine, H (2011) 'Gastroprotective effect of small centaury (Centaurium erythraea L) on aspirin-induced gastric damage in rats', Toxicology and Industrial Health, 27(8), pp. 760-768. doi:10.1177/0748233710397421 Preclinical
https://doi.org/10.1177/0748233710397421 - Chabane, S., Boudjelal, A., Bouaziz-Terrachet, S., Spinozzi, E. et al (2023) 'Analgesic effect of Centaurium erythraea and molecular docking investigation of the major component swertiamarin', Natural Product Research, 38(24), pp. 4511-4517. doi:10.1080/14786419.2023.2278160 Preclinical
https://doi.org/10.1080/14786419.2023.2278160 - Akşit, H., Gözcü, S. and Altay, A (2022) 'Isolation and cytotoxic activities of undescribed iridoid and xanthone glycosides from Centaurium erythraea Rafn. (Gentianaceae)', Phytochemistry, 205, pp. 113484. doi:10.1016/j.phytochem.2022.113484 Preclinical
https://doi.org/10.1016/j.phytochem.2022.113484 - El Menyiy, N., Guaouguaou, F.E., El Baaboua, A., El Omari, N., Taha, D. and others (2021) 'Phytochemical properties, biological activities and medicinal use of Centaurium erythraea Rafn', Journal of Ethnopharmacology, pp. 2021. doi:10.1016/j.jep.2021.114171 Traditional / reference
https://doi.org/10.1016/j.jep.2021.114171 - Guedes, L., Reis, P.B.P.S., Machuqueiro, M., Ressaissi, A., Pacheco, R. and Serralheiro, M.L (2019) 'Bioactivities of Centaurium erythraea (Gentianaceae) Decoctions: Antioxidant Activity, Enzyme Inhibition and Docking Studies', Molecules, 24(20), pp. 3795. doi:10.3390/molecules24203795 Preclinical
https://doi.org/10.3390/molecules24203795 - Dordevic, M., Mihailovic, M., Arambasic Jovanovic, J., Grdovic, N., Uskokovic, A., Tolic, A., Sinadinovic, M., Rajic, J., Misic, D., Siler, B., Poznanovic, G., Vidakovic, M. and Dinic, S (2017) 'Centaurium erythraea methanol extract protects red blood cells from oxidative damage in streptozotocin-induced diabetic rats', Journal of Ethnopharmacology, 202, pp. 172-183. doi:10.1016/j.jep.2017.03.016 Preclinical
https://doi.org/10.1016/j.jep.2017.03.016 - Dordevic, M., Grdovic, N., Mihailovic, M., Arambasic Jovanovic, J., Uskokovic, A., Rajic, J., Sinadinovic, M., Tolic, A., Misic, D., Siler, B., Poznanovic, G., Vidakovic, M. and Dinic, S (2019) 'Centaurium erythraea extract improves survival and functionality of pancreatic beta-cells in diabetes through multiple routes of action', Journal of Ethnopharmacology, 242, pp. 112043. doi:10.1016/j.jep.2019.112043 Preclinical
https://doi.org/10.1016/j.jep.2019.112043 - Chda, A., El Kabbaoui, M., Fresco, P., Silva, D., Goncalves, J., Oliveira, A.P., Andrade, P.B., Valentao, P., Tazi, A., El Abida, K. and Bencheikh, R (2019) 'Centaurium Erythraea Extracts Exert Vascular Effects through Endothelium- and Fibroblast-dependent Pathways', Planta Medica, 86(2), pp. 121-131. doi:10.1055/a-1023-8918 Preclinical
https://doi.org/10.1055/a-1023-8918 - Kumarasamy, Y., Nahar, L., Cox, P.J., Jaspars, M. and Sarker, S.D (2003) 'Bioactivity of secoiridoid glycosides from Centaurium erythraea', Phytomedicine, 10(4), pp. 344-347. doi:10.1078/094471103322004857 Preclinical
https://doi.org/10.1078/094471103322004857 - Kachmar, M.R., Oliveira, A.P., Valentao, P., Gil-Izquierdo, A., Dominguez-Perles, R., Ouahbi, A., Badaoui, K.E., Andrade, P.B. and Ferreres, F (2018) 'HPLC-DAD-ESI/MS phenolic profile and in vitro biological potential of Centaurium erythraea Rafn aqueous extract', Food Chemistry, 278, pp. 424-433. doi:10.1016/j.foodchem.2018.11.082 Preclinical
https://doi.org/10.1016/j.foodchem.2018.11.082 - Mandova, T., Audo, G., Michel, S. and Grougnet, R (2017) 'Off-line coupling of new generation centrifugal partition chromatography device with preparative high pressure liquid chromatography-mass spectrometry triggering fraction collection applied to the recovery of secoiridoid glycosides from Centaurium erythraea Rafn. (Gentianaceae)', Journal of Chromatography A, 1513, pp. 149-156. doi:10.1016/j.chroma.2017.07.023 Preclinical
https://doi.org/10.1016/j.chroma.2017.07.023 - European Medicines Agency (HMPC) (n.d.) 'Assessment report on Centaurium erythraea Rafn s.l., herba (Centaurii herba)'. Available at: https://www.ema.europa.eu/en/documents/herbal-report/assessment-report-centaurium-erythraea-rafn-sl-herba_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-report/assessment-report-centaurium-erythraea-rafn-sl-herba_en.pdf - Herbal Reality (n.d.) 'Centaury (Centaurium erythraea): Benefits, Safety, Uses'. Available at: https://www.herbalreality.com/herb/centaury/ Traditional / reference
https://www.herbalreality.com/herb/centaury/ - European Medicines Agency (HMPC) (2015) 'European Union herbal monograph on Centaurium erythraea Rafn s.l., herba (Centaurii herba)'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/european-union-herbal-monograph-centaurium-erythraea-rafn-sl-herba_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/european-union-herbal-monograph-centaurium-erythraea-rafn-sl-herba_en.pdf
- Mandal, S.K., Maji, A.K., Mishra, S.K., Ishfaq, P.M., Devkota, H.P., Silva, A.S. and Das, N (2020) 'Goldenseal (Hydrastis canadensis L.) and its active constituents: A critical review of their efficacy and toxicological issues', Pharmacological Research. doi:10.1016/j.phrs.2020.105085 Randomized trial
https://doi.org/10.1016/j.phrs.2020.105085 - Corn, J., Tibbitts, D., Ito, H., Schafer, M. and Vasilevsky, N (2021) 'Effects of Hydrastis Canadensis, Commiphora Habessinica, Phytolacca Americana, and Echinacea Purpurea on Bacterial Growth', Alternative Therapies in Health and Medicine, 27(4), pp. 24-27. Preclinical
https://scholar.google.com/scholar?q=Effects%20of%20Hydrastis%20Canadensis%2C%20Commiphora%20Habessinica%2C%20Phytolacca%20Americana%2C%20and%20Echinacea%20Purpurea%20on%20Bacterial%20Growth - Ettefagh, K.A., Burns, J.T., Junio, H.A., Kaatz, G.W. and Cech, N.B (2010) 'Goldenseal (Hydrastis canadensis L.) extracts synergistically enhance the antibacterial activity of berberine via efflux pump inhibition', Planta Medica, 77(8), pp. 835-840. doi:10.1055/s-0030-1250606 Preclinical
https://doi.org/10.1055/s-0030-1250606 - Cech, N.B., Junio, H.A., Ackermann, L.W., Kavanaugh, J.S. and Horswill, A.R (2012) 'Quorum quenching and antimicrobial activity of goldenseal (Hydrastis canadensis) against methicillin-resistant Staphylococcus aureus (MRSA)', Planta Medica, 78(14), pp. 1556--1561. doi:10.1055/s-0032-1315042 Traditional / reference
https://doi.org/10.1055/s-0032-1315042 - Mahady, G.B., Pendland, S.L., Stoia, A. and Chadwick, L.R (2003) 'In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis canadensis', Phytotherapy Research, 17(3), pp. 217-221. doi:10.1002/ptr.1108 Preclinical
https://doi.org/10.1002/ptr.1108 - Junio, H.A., Sy-Cordero, A.A., Ettefagh, K.A., Burns, J.T., Micko, K.T., Graf, T.N., Richter, S.J., Cannon, R.E., Oberlies, N.H. and Cech, N.B (2011) 'Synergy-directed fractionation of botanical medicines: a case study with goldenseal (Hydrastis canadensis)', Journal of Natural Products, 74(7), pp. 1621-1629. doi:10.1021/np200336g Preclinical
https://doi.org/10.1021/np200336g - Britton, E.R., Kellogg, J.J., Kvalheim, O.M. and Cech, N.B (2017) 'Biochemometrics to Identify Synergists and Additives from Botanical Medicines: A Case Study with Hydrastis canadensis (Goldenseal)', Journal of Natural Products, 81(3), pp. 484-493. doi:10.1021/acs.jnatprod.7b00654 Preclinical
https://doi.org/10.1021/acs.jnatprod.7b00654 - Leyte-Lugo, M., Britton, E.R., Foil, D.H., Brown, A.R., Todd, D.A., Rivera-Chavez, J., Oberlies, N.H. and Cech, N.B (2017) 'Secondary Metabolites from the Leaves of the Medicinal Plant Goldenseal (Hydrastis canadensis)', Phytochemistry Letters, 20, pp. 54-60. doi:10.1016/j.phytol.2017.03.012 Preclinical
https://doi.org/10.1016/j.phytol.2017.03.012 - Gurley, B.J., Swain, A., Hubbard, M.A., Hartsfield, F., Thaden, J., Williams, D.K., Gentry, W.B. and Tong, Y (2007) 'Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo', Clinical Pharmacology and Therapeutics, 83(1), pp. 61-69. doi:10.1038/sj.clpt.6100222 Randomized trial
https://doi.org/10.1038/sj.clpt.6100222 - Wallace, E.D., Oberlies, N.H., Cech, N.B. and Kellogg, J.J (2018) 'Detection of adulteration in Hydrastis canadensis (goldenseal) dietary supplements via untargeted mass spectrometry-based metabolomics', Food and Chemical Toxicology, 120, pp. 439-447. doi:10.1016/j.fct.2018.07.033 Preclinical
https://doi.org/10.1016/j.fct.2018.07.033 - Douglas, J.A., Follett, J.M., Parmenter, G.A., Sansom, C.E., Perry, N.B. and Littler, R.A (2010) 'Seasonal variation of biomass and bioactive alkaloid content of goldenseal, Hydrastis canadensis', Fitoterapia, 81(7), pp. 925-928. doi:10.1016/j.fitote.2010.06.006 Preclinical
https://doi.org/10.1016/j.fitote.2010.06.006 - Singh, S., Pathak, N., Fatima, E. and Negi, A.S (2021) 'Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine', European Journal of Medicinal Chemistry. doi:10.1016/j.ejmech.2021.113839 Preclinical
https://doi.org/10.1016/j.ejmech.2021.113839 - World Health Organization (2007) 'Rhizoma Hydrastis'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 - Sevior, D.K., Hokkanen, J., Tolonen, A., Abass, K., Tursas, L., Pelkonen, O. and Ahokas, J.T (2010) 'Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktail', Xenobiotica, 40(4), pp. 245--254. doi:10.3109/00498251003592683 Preclinical
https://doi.org/10.3109/00498251003592683 - Gurley, B.J., Gardner, S.F., Hubbard, M.A., Williams, D.K., Gentry, W.B., Khan, I.A. and Shah, A (2005) 'In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes', Clinical Pharmacology and Therapeutics, 77(5), pp. 415-426. doi:10.1016/j.clpt.2005.01.009 Randomized trial
https://doi.org/10.1016/j.clpt.2005.01.009 - McDonald, M.G., Tian, D.D., Thummel, K.E., Paine, M.F. and Rettie, A.E (2020) 'Modulation of major human liver microsomal cytochromes P450 by component alkaloids of goldenseal: time-dependent inhibition and allosteric effects', Drug Metabolism and Disposition, 48(10), pp. 1018-1027. doi:10.1124/dmd.120.091041 Preclinical
https://doi.org/10.1124/dmd.120.091041 - Guo, J., Chen, H., Zhang, X., Lou, W., Zhang, P., Qiu, Y., Zhang, C., Wang, Y. and Liu, W.J (2021) 'The effect of berberine on metabolic profiles in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials', Oxidative Medicine and Cellular Longevity, 2021, pp. 2074610. doi:10.1155/2021/2074610 Meta-analysis / review
https://doi.org/10.1155/2021/2074610 - Forest Farming (Cooperative Extension) 'Goldenseal (Hydrastis canadensis L.)'. Available at: https://forest-farming.extension.org/goldenseal-hydrastis-canadensis-l/ Traditional / reference
https://forest-farming.extension.org/goldenseal-hydrastis-canadensis-l/ - Frasca, T. and Brett, A.S. and Yoo, S.D (1997) 'Mandrake toxicity. A case of mistaken identity', Archives of Internal Medicine, 157(17), pp. 2007-9. doi:10.1001/archinte.157.17.2007 Clinical study
https://doi.org/10.1001/archinte.157.17.2007 - North Carolina Extension Gardener Plant Toolbox 'Sanguinaria canadensis (Bloodroot)'. Available at: https://plants.ces.ncsu.edu/plants/sanguinaria-canadensis/ Traditional / reference
https://plants.ces.ncsu.edu/plants/sanguinaria-canadensis/
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.